These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35216709)

  • 61. Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus.
    Morgunov LY; Denisova IA; Rozhkova TI; Stakhovskaya LV; Skvortsova VI
    Aging Male; 2020 Mar; 23(1):71-80. PubMed ID: 30064273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nonfunctional pituitary macroadenoma manifested as muscular symptoms.
    Matsubara A; Tamura A; Matsumura S; Yokoya H; Maruyama S; Kobayashi K; Kawamoto Y; Teishima J; Seki M; Usui T
    Hiroshima J Med Sci; 2006 Dec; 55(4):117-20. PubMed ID: 17274542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypopituitarism.
    Ascoli P; Cavagnini F
    Pituitary; 2006; 9(4):335-42. PubMed ID: 17077946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sperm Count and Hypogonadism as Markers of General Male Health.
    Ferlin A; Garolla A; Ghezzi M; Selice R; Palego P; Caretta N; Di Mambro A; Valente U; De Rocco Ponce M; Dipresa S; Sartori L; Plebani M; Foresta C
    Eur Urol Focus; 2021 Jan; 7(1):205-213. PubMed ID: 31427194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes.
    Cai M; Cui R; Yang P; Gao J; Cheng X; Sheng C; Li H; Sheng H; Qu S; Zhang M
    Front Endocrinol (Lausanne); 2021; 12():675525. PubMed ID: 34135863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.
    Duarte RV; Raphael JH; Labib M; Southall JL; Ashford RL
    Pain Physician; 2013 Jan; 16(1):9-14. PubMed ID: 23340538
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Male hypogonadism : an update on diagnosis and treatment.
    Darby E; Anawalt BD
    Treat Endocrinol; 2005; 4(5):293-309. PubMed ID: 16185098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypogonadism and liver fibrosis in HIV-infected patients.
    Quiros-Roldan E; Porcelli T; Pezzaioli LC; Degli Antoni M; Paghera S; Properzi M; Focà E; Carriero C; Castelli F; Ferlin A
    J Endocrinol Invest; 2021 Sep; 44(9):1971-1979. PubMed ID: 33515211
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Androgen deficiency and type 2 diabetes mellitus.
    Gibb FW; Strachan MW
    Clin Biochem; 2014 Jul; 47(10-11):940-9. PubMed ID: 24768826
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
    Ogbera OA; Sonny C; Olufemi F; Wale A
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group.
    Ganesh HK; Vijaya Sarathi HA; George J; Shivane VK; Bandgar T; Menon PS; Shah NS
    Endocr Pract; 2009; 15(6):513-20. PubMed ID: 19454386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study.
    Katznelson L; Kleinberg D; Vance ML; Stavrou S; Pulaski KJ; Schoenfeld DA; Hayden DL; Wright ME; Woodburn CJ; Klibanski A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):183-8. PubMed ID: 11207632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents.
    Hermoso DAM; Bizerra PFV; Constantin RP; Ishii-Iwamoto EL; Gilglioni EH
    Aging Male; 2020 Dec; 23(5):1296-1315. PubMed ID: 32406295
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Androgen deficiency in women with hypopituitarism.
    Miller KK; Sesmilo G; Schiller A; Schoenfeld D; Burton S; Klibanski A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):561-7. PubMed ID: 11158009
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of hypogonadism in Klinefelter syndrome.
    Høst C; Skakkebæk A; Groth KA; Bojesen A
    Asian J Androl; 2014; 16(2):185-91. PubMed ID: 24407186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypogonadism and cancer survivorship.
    Faw CA; Brannigan RE
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):411-418. PubMed ID: 33003070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.